TY - JOUR
T1 - Prone-to-Infectivity of Omicron BA.2 Subvariant from Indonesia on ACE-2 Expressing Cell Lines
AU - Hidayati, Wahyu
AU - Hidayati, Desti
AU - Khairindra, Fathur Luthfiano
AU - Umakappa, Munawir
AU - Sudarmono, Pratiwi Pudjilestari
AU - Farida, Siti
AU - Wirabrata, I. Gede Made
AU - Dewi, Beti Ernawati
N1 - Publisher Copyright:
© 2024, Penerbit Akademia Baru. All rights reserved.
PY - 2024/7
Y1 - 2024/7
N2 - SARS-CoV-2 virus undergoes mutation, leading to the virus's evolution and modifications in the characteristics of the virus. Omicron, including BA.2 subvariant, is currently the predominant variant in SARS-CoV-2 infection. There are no reports regarding its properties or the utilization of BA.2 Indonesian isolate for therapy and vaccine development. Therefore, this study evaluated appropriate host cells for Omicron BA.2 Indonesian isolate via susceptibility tests. The Omicron BA.2 from Indonesia was exposed to three mammalian-ACE2-expressing cell lines. Sharing amino acids between BA.2 from Indonesia and previous VOC Omicron subvariants was performed using a simple in silico comparison method. The results showed that the virus could not infect HepG2 and Huh-7D12 due to no foci forming on those cell lines. Moreover, we also found that BA.2 Indonesian isolate has a unique amino acid alteration on spike protein. According to the findings, the Omicron BA.2 from Indonesia could propagate on Vero E6 cell lines, and the mutations could play a role in the virus's changing infection mechanism. A deeper in vitro and in silico experiment could enhance the findings by comparing all BA.2 sequences from Indonesia and analyzing the infection mechanism by each single mutation using pseudovirus.
AB - SARS-CoV-2 virus undergoes mutation, leading to the virus's evolution and modifications in the characteristics of the virus. Omicron, including BA.2 subvariant, is currently the predominant variant in SARS-CoV-2 infection. There are no reports regarding its properties or the utilization of BA.2 Indonesian isolate for therapy and vaccine development. Therefore, this study evaluated appropriate host cells for Omicron BA.2 Indonesian isolate via susceptibility tests. The Omicron BA.2 from Indonesia was exposed to three mammalian-ACE2-expressing cell lines. Sharing amino acids between BA.2 from Indonesia and previous VOC Omicron subvariants was performed using a simple in silico comparison method. The results showed that the virus could not infect HepG2 and Huh-7D12 due to no foci forming on those cell lines. Moreover, we also found that BA.2 Indonesian isolate has a unique amino acid alteration on spike protein. According to the findings, the Omicron BA.2 from Indonesia could propagate on Vero E6 cell lines, and the mutations could play a role in the virus's changing infection mechanism. A deeper in vitro and in silico experiment could enhance the findings by comparing all BA.2 sequences from Indonesia and analyzing the infection mechanism by each single mutation using pseudovirus.
KW - ACE-2
KW - COVID-19
KW - Indonesia
KW - Omicron
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85201266492&partnerID=8YFLogxK
U2 - 10.37934/armne.21.1.5465
DO - 10.37934/armne.21.1.5465
M3 - Article
AN - SCOPUS:85201266492
SN - 2756-8210
VL - 21
SP - 54
EP - 65
JO - Journal of Advanced Research in Micro and Nano Engineering
JF - Journal of Advanced Research in Micro and Nano Engineering
IS - 1
ER -